| Composition | Voglibose 0.3mg Metformin Hydrochloride 500mg |
|---|---|
| Dosage | TABLET |
| Packing Size | 20×10 |
| Packing | Blister |
At Avecia Healthcare, we believe that professionalism forms the foundation of trust. Our expert team is committed to providing healthcare solutions that meet global standards.
Every product we deliver is a result of thorough research, precision manufacturing, and rigorous quality checks—ensuring consistency in performance and reliability.
With a patient-first approach and a strong ethical foundation, we aim to make a lasting difference in lives by offering care that is both dependable and professionally crafted.
VOGLICOP M 0.3/500 Tablets
VOGLICOP M 0.3/500 is a powerful antidiabetic combination tablet designed to support effective management of type 2 diabetes. It combines two active ingredients in a precise 0.3/500 mg dosage to regulate blood sugar levels and improve overall glycemic control.
This formulation works by enhancing insulin sensitivity and reducing glucose production in the liver, providing consistent blood sugar management throughout the day. VOGLICOP M 0.3/500 is suitable for patients who need a comprehensive approach to controlling diabetes beyond monotherapy.
Regular use of VOGLICOP M 0.3/500 helps prevent sudden blood sugar spikes and dips, reducing the risk of long-term complications such as kidney problems, neuropathy, and cardiovascular issues. It is often prescribed as part of a holistic diabetes care plan, including diet, exercise, and routine monitoring of glucose levels.
Patients appreciate VOGLICOP M 0.3/500 for its reliable efficacy and convenient dosage, which supports adherence to daily treatment. With its well-balanced formulation, VOGLICOP M 0.3/500 Tablets provide a safe and effective solution for maintaining healthy blood sugar levels, promoting overall wellness and improving quality of life for individuals managing type 2 diabetes.
